¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"pacemaker cell"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
  • lymphosarcoma cell leukemia
    ¸²ÇÁÀ°Á¾¼¼Æ÷¹éÇ÷º´
  • lacunar cell
    °ø°£¼¼Æ÷
  • mitotic cell
    À¯»çºÐ¿­±â¼¼Æ÷
  • mitral cell
    ½Â¸ð¼¼Æ÷
  • mixed germ cell tumor
    È¥ÇÕÁ¾ÀÚ¼¼Æ÷Á¾¾ç
  • monocyte-macrophage cell system
    ´ÜÇÙ±¸Å«Æ÷½Ä¼¼Æ÷°èÅë, ´ÜÇÙ±¸´ë½Ä¼¼Æ÷°èÅë
  • mononuclear cell
    ´ÜÇÙ¼¼Æ÷, ´ÜÇÙ±¸
  • mossy cell
    À̳¢¼¼Æ÷
  • mother cell
    ¸ð¼¼Æ÷, ¾î¹Ì¼¼Æ÷
  • motor cell
    ¿îµ¿½Å°æ¼¼Æ÷
  • mucous cell
    Á¡¾×¼¼Æ÷
  • mulberry cell
    ¿Àµð¼¼Æ÷
  • multinuclear giant cell
    ´ÙÇÙ°Å´ë¼¼Æ÷, ¹µÇÙ°Å´ë¼¼Æ÷
  • multipolar nerve cell
    ´Ù±Ø½Å°æ¼¼Æ÷, ¹µ±Ø½Å°æ¼¼Æ÷
  • myeloid cell
    °ñ¼ö¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
  • packed red blood cell
    ³óÃàÀûÇ÷±¸
  • parafollicular cell
    ¼ÒÆ÷°ç¼¼Æ÷
  • paralutein cell
    ȲüÁÖÀ§¼¼Æ÷, ºÎȲü¼¼Æ÷
  • parietal cell
    º®¼¼Æ÷
  • pathologic cell
    º´Àû¼¼Æ÷
  • perivascular cell
    Ç÷°üÁÖÀ§¼¼Æ÷
  • phagocytic cell
    Æ÷½Ä¼¼Æ÷
  • pheochrome cell
    ºÎ½Åģũ·Ò¼¼Æ÷
  • photoreceptor cell
    (¢¡visual cell) ½Ã°¢¼¼Æ÷
  • physaliphorous cell
    ´ã°øÆ÷¼¼Æ÷
  • pigment cell
    »ö¼Ò¼¼Æ÷
  • pillar cell
    ±âµÕ¼¼Æ÷
  • pilomotor cell
    Åп½Å°æ¼¼Æ÷
  • plasma cell
    ÇüÁú¼¼Æ÷
  • pluripotential cell
    ´Ù´É¼º¼¼Æ÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
  • hypersensitivity reactions,type ii(antibody-dependent cell-mediate cyt
    IIÇü
  • hypersensitivity reactions,type iv(cell-mediated)
    IVÇü
  • hypersensitivity, cell-mediated
    ¼¼Æ÷¸Å°³ °ú¹Î¹ÝÀÀ
  • hypersensitized cell
    °ú°¨ÀÛ¼¼Æ÷.
  • hypoglycemia, beta cell tumor
    ÀúÇ÷´ç(Áõ), º£Å¸¼¼Æ÷Á¾
  • hypoxic cell
    Àú»ê¼Ò¼¼Æ÷
  • hypoxic cell sensitizer
    Àú»ê¼Ò¼¼Æ÷°¨ÀÛÁ¦
  • i-cell disease
    I-¼¼Æ÷º´
  • idiotype specific regulatory cell
    °³º°Æ¯ÀÌÇü Á¶Àý¼¼Æ÷
  • immortalized cell
    ¹«ÇÑÁõ½Ä¼¼Æ÷
  • immunity,cell-mediated
    ¼¼Æ÷¸Å°³¼º(á¬øàØÚË¿àõ)
  • immunocompetent cell
    ¸é¿ªÀû°Ý¼¼Æ÷.
  • immunodeficiency syndrome, cell mediated
    ¼¼Æ÷¸Å°³ ¸é¿ª°áÇÌ ÁõÈıº
  • immunologically committed cell
    ¸é¿ª°æÇè¼¼Æ÷(¡­ÌèúÐá¬øà).
  • immunologically competent cell
    ¸é¿ªÀû°Ý¼¼Æ÷(¡­îêÌ«á¬øà).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
  • cell surface receptor
    ¼¼Æ÷Ç¥¸é¼ö¿ëü
  • cell survival curve
    ¼¼Æ÷»ýÁ¸°î¼±
  • cell transformation
    ¼¼Æ÷ÇüÁúÀüȯ, ¼¼Æ÷º¯Çü
  • cell typing
    Ç÷±¸Çü°Ë»ç
  • cell wall
    ¼¼Æ÷º®
  • cell wall
    ¼¼Æ÷º®.
  • cell wall antigen
    ¼¼Æ÷º®Ç׿ø
  • cell wall inhibitor
    ¼¼Æ÷º®ÇÕ¼º¾ïÁ¦Á¦
  • cell wall teichoic acid
    ¼¼Æ÷º® ŸÀÌÄÚ»ê
  • cell, HeLa
    HeLa¼¼Æ÷
  • cell, K
    K¼¼Æ÷, »ìÇØ¼¼Æ÷
  • cell, T
    T¼¼Æ÷
  • cell, committed T
    ¼öÀÓT¼¼Æ÷
  • cell, dendritic
    ¼öÁö»ó¼¼Æ÷
  • cell, dendritic reticular <-lum>
    ¼öÁö¸Á»ó¼¼Æ÷
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 18
  • ¿µ¹®
    ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á